{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:04:54Z","timestamp":1794611094703,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We propose a consensus definition of \u201can exaggerated orthostatic pressor response\u201d in subjects in whom systolic blood pressure increases \u226520\u2009mmHg when going from the supine to standing posture. This definition can be extended for seated to standing measurements. We reserve the term \u201corthostatic hypertension\u201d if this pressor response leads to an upright systolic blood pressure \u2265140\u2009mmHg. We believe this consensus definition will help in the study of the pathophysiology, clinical impact, and potential treatment of these entities, and the identification of patients that are at greater cardiovascular risk.<\/jats:p>","DOI":"10.1038\/s41440-022-01074-0","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T07:02:33Z","timestamp":1669186953000},"page":"291-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension"],"prefix":"10.1038","volume":"46","author":[{"given":"Jens","family":"Jordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Biaggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Kotsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Fedorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"1074_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/HYPERTENSIONAHA.120.14340","volume":"75","author":"J Jordan","year":"2020","unstructured":"Jordan J, Ricci F, Hoffmann F, Hamrefors V, Fedorowski A. Orthostatic hypertension: critical appraisal of an overlooked condition. Hypertension. 2020;75:1151\u20138.","journal-title":"Hypertension"},{"key":"1074_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrneph.2013.224","volume":"9","author":"K Kario","year":"2013","unstructured":"Kario K. Orthostatic hypertension\u2013a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol. 2013;9:726\u201338.","journal-title":"Nat Rev Nephrol"},{"key":"1074_CR3","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e127\u2013e248.","DOI":"10.1016\/j.jacc.2017.11.006"},{"key":"1074_CR4","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953\u20132041.","journal-title":"J Hypertens"},{"key":"1074_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"1074_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/eurheartj\/ehp329","volume":"31","author":"A Fedorowski","year":"2010","unstructured":"Fedorowski A, Stavenow L, Hedblad B, Berglund G, Nilsson PM, Melander O. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J. 2010;31:85\u201391.","journal-title":"Eur Heart J"},{"key":"1074_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10654-020-00695-4","volume":"36","author":"L Brunkwall","year":"2021","unstructured":"Brunkwall L, J\u00f6nsson D, Ericson U, Hellstrand S, Kennb\u00e4ck C, \u00d6stling G, et al. The Malm\u00f6 Offspring Study (MOS): design, methods and first results. Eur J Epidemiol. 2021;36:103\u201316.","journal-title":"Eur J Epidemiol"},{"key":"1074_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10286-019-00606-y","volume":"29","author":"C Finucane","year":"2019","unstructured":"Finucane C, van Wijnen VK, Fan CW, Soraghan C, Byrne L, Westerhof BE, et al. A practical guide to active stand testing and analysis using continuous beat-to-beat non-invasive blood pressure monitoring. Clin Auton Res. 2019;29:427\u201341.","journal-title":"Clin Auton Res"},{"key":"1074_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/hr.2016.70","volume":"39","author":"T Komori","year":"2016","unstructured":"Komori T, Eguchi K, Kario K. The measurement of orthostatic blood pressure as a screening tool for masked hypertension with abnormal circadian blood pressure rhythm. Hypertens Res. 2016;39:631\u20132.","journal-title":"Hypertens Res"},{"key":"1074_CR10","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1161\/01.HYP.31.5.1178","volume":"31","author":"J Jordan","year":"1998","unstructured":"Jordan J, Shannon JR, Black BK, Lance RH, Squillante MD, Costa F, et al. NN-nicotinic blockade as an acute human model of autonomic failure. Hypertension. 1998;31:1178\u201384.","journal-title":"Hypertension"},{"key":"1074_CR11","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jacc.2018.05.079","volume":"72","author":"R Freeman","year":"2018","unstructured":"Freeman R, Abuzinadah AR, Gibbons C, Jones P, Miglis MG, Sinn DI. Orthostatic hypotension: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72:1294\u2013309.","journal-title":"J Am Coll Cardiol"},{"key":"1074_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/01.HYP.7.2.196","volume":"7","author":"DH Streeten","year":"1985","unstructured":"Streeten DH, Auchincloss-JH J, Anderson-GH J, Richardson RL, Thomas FD, Miller JW. Orthostatic hypertension. Pathogenetic Stud Hypertension. 1985;7:196\u2013203.","journal-title":"Pathogenetic Stud Hypertension"},{"key":"1074_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S0895-7061(96)00489-X","volume":"10","author":"O Vriz","year":"1997","unstructured":"Vriz O, Soon G, Lu H, Weder AB, Canali C, Palatini P. Does orthostatic testing have any role in the evaluation of the young subject with mild hypertension?: an insight from the HARVEST study. Am J Hypertens. 1997;10:546\u201351.","journal-title":"Am J Hypertens"},{"key":"1074_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/01.HYP.31.1.77","volume":"31","author":"K Kario","year":"1998","unstructured":"Kario K, Eguchi K, Nakagawa Y, Motai K, Shimada K. Relationship between extreme dippers and orthostatic hypertension in elderly hypertensive patients. Hypertension. 1998;31:77\u201382.","journal-title":"Hypertension"},{"key":"1074_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0735-1097(02)01923-X","volume":"40","author":"K Kario","year":"2002","unstructured":"Kario K, Eguchi K, Hoshide S, Hoshide Y, Umeda Y, Mitsuhashi T, et al. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol. 2002;40:133\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"1074_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/hr.2011.156","volume":"35","author":"S Hoshide","year":"2012","unstructured":"Hoshide S, Parati G, Matsui Y, Shibazaki S, Eguchi K, Kario K. Orthostatic hypertension: home blood pressure monitoring for detection and assessment of treatment with doxazosin. Hypertens Res. 2012;35:100\u20136.","journal-title":"Hypertens Res"},{"key":"1074_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41371-019-0180-4","volume":"33","author":"WJ Kostis","year":"2019","unstructured":"Kostis WJ, Sargsyan D, Mekkaoui C, Moreyra AE, Cabrera J, Cosgrove NM, et al. Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly Program. J Hum hypertension. 2019;33:735\u201340.","journal-title":"J Hum hypertension"},{"key":"1074_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/01.HYP.33.5.1123","volume":"33","author":"CJ Nardo","year":"1999","unstructured":"Nardo CJ, Chambless LE, Light KC, Rosamond WD, Sharrett AR, Tell GS, et al. Descriptive epidemiology of blood pressure response to change in body position. The ARIC study. Hypertension. 1999;33:1123\u20139.","journal-title":"Hypertension"},{"key":"1074_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/HJH.0b013e32834fa860","volume":"30","author":"A Fedorowski","year":"2012","unstructured":"Fedorowski A, Ostling G, Persson M, Struck J, Engstrom G, Nilsson PM, et al. Orthostatic blood pressure response, carotid intima-media thickness, and plasma fibrinogen in older nondiabetic adults. J Hypertens. 2012;30:522\u20139.","journal-title":"J Hypertens"},{"key":"1074_CR20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1161\/HYPERTENSIONAHA.116.07474","volume":"68","author":"JL Fleg","year":"2016","unstructured":"Fleg JL, Evans GW, Margolis KL, Barzilay J, Basile JN, Bigger JT, et al. Orthostatic hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: prevalence, incidence, and prognostic significance. Hypertension. 2016;68:888\u201395.","journal-title":"Hypertension"},{"key":"1074_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jash.2016.08.005","volume":"10","author":"RR Townsend","year":"2016","unstructured":"Townsend RR, Chang TI, Cohen DL, Cushman WC, Evans GW, Glasser SP, et al. Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. J Am Soc Hypertension. 2016;10:847\u201356.","journal-title":"J Am Soc Hypertension"},{"key":"1074_CR22","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2337\/diacare.24.10.1783","volume":"24","author":"M Yoshinari","year":"2001","unstructured":"Yoshinari M, Wakisaka M, Nakamura U, Yoshioka M, Uchizono Y, Iwase M. Orthostatic hypertension in patients with type 2 diabetes. Diabetes Care. 2001;24:1783\u20136.","journal-title":"Diabetes Care"},{"key":"1074_CR23","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0025-6196(11)63142-X","volume":"78","author":"RJ Thomas","year":"2003","unstructured":"Thomas RJ, Liu K, Jacobs DR Jr, Bild DE, Kiefe CI, Hulley SB. Positional change in blood pressure and 8-year risk of hypertension: the CARDIA Study. Mayo Clin Proc. 2003;78:951\u20138.","journal-title":"Mayo Clin Proc"},{"key":"1074_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ajh.2010.76","volume":"23","author":"XH Fan","year":"2010","unstructured":"Fan XH, Wang Y, Sun K, Zhang W, Wang H, Wu H, et al. Disorders of orthostatic blood pressure response are associated with cardiovascular disease and target organ damage in hypertensive patients. Am J Hypertens. 2010;23:829\u201337.","journal-title":"Am J Hypertens"},{"key":"1074_CR25","doi-asserted-by":"crossref","unstructured":"Juraschek SP, Daya N, Appel LJ, Miller ER III, McEvoy JW, Matsushita K, et al. Orthostatic hypotension and risk of clinical and subclinical cardiovascular disease in middle-aged adults. J Am Heart Assoc. 2018;7:e008884.","DOI":"10.1161\/JAHA.118.008884"},{"key":"1074_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.110.161844","volume":"57","author":"H Yatsuya","year":"2011","unstructured":"Yatsuya H, Folsom AR, Alonso A, Gottesman RF, Rose KM. Postural changes in blood pressure and incidence of ischemic stroke subtypes: the ARIC study. Hypertension. 2011;57:167\u201373.","journal-title":"Hypertension"},{"key":"1074_CR27","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/ajh\/hpv022","volume":"28","author":"N Veronese","year":"2015","unstructured":"Veronese N, De Rui M, Bolzetta F, Zambon S, Corti MC, Baggio G, et al. Orthostatic changes in blood pressure and mortality in the elderly: the Pro.V.A Study. Am J Hypertens. 2015;28:1248\u201356.","journal-title":"Am J Hypertens"},{"key":"1074_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1161\/HYPERTENSIONAHA.115.06386","volume":"67","author":"D Agnoletti","year":"2016","unstructured":"Agnoletti D, Valbusa F, Labat C, Gautier S, Mourad JJ, Benetos A. Evidence for a prognostic role of orthostatic hypertension on survival in a very old institutionalized population. Hypertension. 2016;67:191\u20136.","journal-title":"Hypertension"},{"key":"1074_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/hr.2017.39","volume":"40","author":"AC Breeuwsma","year":"2017","unstructured":"Breeuwsma AC, Hartog LC, Kamper AM, Groenier KH, Bilo HJ, Kleefstra N, et al. Standing orthostatic blood pressure measurements cannot be replaced by sitting measurements. Hypertens Res. 2017;40:765\u2013770.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01074-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01074-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01074-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:10:12Z","timestamp":1675642212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01074-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1074"],"URL":"https:\/\/doi.org\/10.1038\/s41440-022-01074-0","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"11 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JJ served as an advisor for Novo-Nordisk and Bayer, received research support from Boehringer Ingelheim and Novo-Nordisk, and is co-founder of Eternygen GmbH. He is the Editor-in-Chief of <i>Clinical Autonomic Research<\/i> and International Associate Editor of <i>Hypertension Research<\/i> but was not involved in the editorial handling of this manuscript. IB is a consultant for Theravance Biopharma, Takeda Inc., and Amneal Pharmaceuticals, and has a patent for an automated abdominal binder to treat orthostatic hypotension. He is supported by NIH grants R01HL149386 and R01HL161095. VK, PN, GG, and AF report no conflicts of interest. KK is the Editor-in-Chief of <i>Hypertension Research<\/i> but was not involved in the editorial handling of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}